Rocket Pharmaceuticals (RCKT) Earnings Date, Estimates & Call Transcripts $6.07 -0.55 (-8.31%) As of 03:21 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rocket Pharmaceuticals Earnings Summary Rocket Pharmaceuticals announced Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.56, which beat the consensus estimate of -$0.58 by $0.02. With a trailing EPS of -$2.63, Rocket Pharmaceuticals' earnings are expected to grow next year, from ($2.83) to ($2.22) per share. Latest Q1 Earnings DateMay. 13EstimatedConsensus EPS (May. 13) -$0.58 Actual EPS (May. 13) -$0.56 Beat By $0.02 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)Powered by Get Rocket Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rocket Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRCKT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Rocket Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.84-$0.59-$0.72Q2 20253-$0.79-$0.51-$0.63Q3 20252-$0.81-$0.56-$0.69Q4 20253-$0.77-$0.50-$0.61 FY 2025 10 -$3.21 -$2.16 -$2.65 Q1 20261-$0.27-$0.27-$0.27Q2 20261-$0.07-$0.07-$0.07Q3 20261$0.05$0.05$0.05Q4 20261$0.25$0.25$0.25 Rocket Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/13/2025--$0.58-$0.56+$0.02---5/5/2025Q1 2025-$0.59-$0.56+$0.03-$0.56$0.80M-3/3/2025Q4 2024-$0.68-$0.62+$0.06-$0.62$0.03M-11/7/2024--$0.78-$0.71+$0.07-$0.71--8/5/2024Q2 2024-$0.72-$0.74 -$0.02-$0.74--5/6/2024Q1 2024-$0.67-$0.66+$0.01-$0.66--2/26/2024Q4 2023-$0.78-$0.64+$0.14-$0.64--11/6/2023Q3 2023-$0.81-$0.75+$0.06-$0.75--8/10/2023Q2 2023-$0.81-$0.82 -$0.01-$0.82-- Rocket Pharmaceuticals Earnings - Frequently Asked Questions When did Rocket Pharmaceuticals announce their last quarterly earnings? Rocket Pharmaceuticals (NASDAQ:RCKT) last announced its quarterly earning data on Tuesday, May 13, 2025. Learn more on RCKT's earnings history. Did Rocket Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Rocket Pharmaceuticals (NASDAQ:RCKT) reported ($0.56) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.58) by $0.02. Learn more on analysts' earnings estimate vs. RCKT's actual earnings. How much profit does Rocket Pharmaceuticals generate each year? Rocket Pharmaceuticals (NASDAQ:RCKT) has a recorded net income of -$245.60 million. RCKT has generated -$2.63 earnings per share over the last four quarters. What is Rocket Pharmaceuticals's EPS forecast for next year? Rocket Pharmaceuticals's earnings are expected to grow from ($2.83) per share to ($2.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies Merus Earnings Results ACADIA Pharmaceuticals Earnings Results Catalyst Pharmaceuticals Earnings Results Protagonist Therapeutics Earnings Results Metsera Earnings Results Xenon Pharmaceuticals Earnings Results MoonLake Immunotherapeutics Earnings Results Immunovant Earnings Results Amneal Pharmaceuticals Earnings Results Organon & Co. Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery? This page (NASDAQ:RCKT) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredBITCOIN Liquidity pools are the backbone of crypto—and right now, they’re exploding with activity. By providing liqui...Awesomely, LLC | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RCKT Stock Free RCKT Stock Alerts